Sionna Therapeutics (SION) Long-Term Investments (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Long-Term Investments data on file, last reported at $73.8 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments fell 13.18% year-over-year to $73.8 million; the trailing twelve-month figure through Mar 2026 stood at $73.8 million (down 13.18% YoY), and the FY2025 full-year result was $74.4 million, up 262.94% from the prior year.
• Long-Term Investments retreated to $73.8 million in Q1 2026, from $74.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $85.0 million in Q1 2025 to a low of $20.5 million in Q4 2024.
• A 3-year average of $67.5 million and a median of $74.6 million in 2025 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments soared 262.94% in 2025 and slipped 13.18% in 2026, its largest moves.
• Tracing SION's Long-Term Investments over 3 years: stood at $20.5 million in 2024, then soared by 262.94% to $74.4 million in 2025, then decreased by 0.83% to $73.8 million in 2026.
• Business Quant data shows SION's Long-Term Investments at $73.8 million in Q1 2026, $74.4 million in Q4 2025, and $76.7 million in Q3 2025.